|
WO2017095489A1
|
|
Use of microrna precursors as drugs for inducing cd34-positive adult stem cell expansion
|
|
US2016289682A1
|
|
Production and utilization of a novel anti-cancer drug in therapy
|
|
TW201629227A
|
|
Production and utilization of a novel anti-cancer drug in therapy
|
|
WO2015112312A1
|
|
Monosaccharide-like glycylated sugar alcohol compositions for use as anti-diabetic drugs
|
|
US2014350085A1
|
|
Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
|
|
CN106102777A
|
|
For in organism and the novel sugar alcohol system constituent of delivered in vitro nucleic acid system medicine
|
|
US2014141470A1
|
|
Production and extraction of MicroRNA precursor as drug for cancer therapy
|
|
US2013324590A1
|
|
Production and utilization of a novel anti-cancer drug in therapy
|
|
EP2882859A2
|
|
Production and utilization of a novel anti-cancer drug in therapy
|
|
US2010240126A1
|
|
Development of universal cancer drugs and vaccines
|
|
CN101970664A
|
|
Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
|
|
US2009203141A1
|
|
Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
|
|
WO2009058893A2
|
|
Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic rnas
|
|
US2008293143A1
|
|
Generation of human embryonic stem-like cells using intronic RNA
|
|
US2009170204A1
|
|
Cosmetic designs and products using intronic RNA
|
|
US2006228800A1
|
|
Novel Transgenic Methods Using intronic RNA
|
